PCM
SGEN

Prelude Capital Management’s Seagen Inc. Common Stock SGEN Stock Holding History

Prelude Capital Management’s Portfolio SGEN Stock Details SGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-43,300
Closed -$5K – 1729
2022
Q3 		$5K Buy
+43,300
New +$7.05M ﹤0.01% 1366
2020
Q2 		– Sell
-200
Closed -$23K – 2325
2020
Q1 		$23K Buy
+200
New +$22.1K ﹤0.01% 955

Other funds holding SGEN

SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FBC
Fairfield, Bush & Co Darien, Connecticut $180M AUM 39.51% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
SAG
Spotlight Asset Group Oakbrook Terrace, Illinois $143M AUM 20.66% 1-Year Est. Return

Prelude Capital Management's SGEN Position: Q4 2023 in Review

Prelude Capital Management sold out of Seagen Inc. Common Stock (SGEN) in Q4 2023, closing a stake of 45,404 shares — an estimated $9.63M sold.

Prelude Capital Management first reported a position in SGEN in Q2 2013 and held it in 28 quarters. The position peaked at $9.63M in Q3 2023. 6 funds tracked by Wall St. Rank hold SGEN as of Q4 2023.

  • Prelude Capital Management reported no remaining Seagen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Prelude Capital Management sold 45,404 Seagen Inc. Common Stock shares in Q4 2023, an estimated $9.63M.
  • Prelude Capital Management first reported a position in Seagen Inc. Common Stock in Q2 2013 and held it in 28 quarters.
  • Prelude Capital Management's Seagen Inc. Common Stock position peaked at $9.63M in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2023.

Based on Prelude Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.